BioNTech SE (BNTX)

Growth

Revenue 5Y-
Revenue 3Y410.28%
EPS 5Y-
EPS 3Y478.36%
Dividend 5Y-
Dividend 3Y-

Capital Efficiency

ROIC75.12%
ROE65.53%
ROA45.55%
ROTA45.55%

Capital Structure

Market Cap34.25B
EV21.10B
Cash13.42B
Current Ratio5.37
Debt/Equity0.19
Net Debt/EBITDA-0.90
Show More

Income Statement

Select a metric from the list below to chart it

Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Income Statement
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Revenue
67.2
139.2
118.5
526.3
20,705.6
20,256.2
Revenue % Chg.
-
107.1%
-14.9%
344.2%
3834.4%
34.6%
Cost of Revenue
10.2
14.9
18.9
64.7
4,212.4
5,121.0
Cost of Revenue % Chg.
-
46.9%
26.8%
241.8%
6406.8%
98.1%
Gross Profit
57.0
124.3
99.5
461.5
16,493.2
15,135.2
Gross Profit % Chg.
-
117.8%
-19.9%
363.7%
3473.6%
21.5%
Gross Profit Margin
84.9%
89.3%
84.0%
87.7%
79.7%
74.7%
Gross Profit Margin % Chg.
-
5.2%
-5.9%
4.4%
-9.2%
-9.8%
R&D Expenses
93.3
156.1
247.1
706.0
-
-
R&D Expenses % Chg.
-
67.3%
58.3%
185.7%
-
-
Selling, General, & Admin Expenses
32.2
29.6
47.4
110.7
358.9
603.3
Selling, General, & Admin Expenses % Chg.
-
-8.1%
60.2%
133.6%
224.3%
151.4%
Other Expenses
-1.6
-2.6
3.1
-257.6
-140.5
-100.5
Other Expenses % Chg.
-
67.2%
-
-
45.4%
71.0%
Operating Income
-66.9
-58.8
-198.1
-89.9
16,676.3
15,329.5
Operating Income % Chg.
-
12.1%
237.1%
54.6%
-
29.7%
Operating Income Margin
-99.5%
-42.2%
-167.2%
-17.1%
80.5%
75.7%
Operating Income Margin % Chg.
-
57.6%
296.0%
89.8%
-
-3.6%
Total Other Income/Expenses Net
-26.9
6.8
2.3
-69.2
-259.0
486.5
Total Other Income/Expenses Net % Chg.
-
-
-66.4%
-
274.5%
-
Income Before Tax
-93.7
-52.0
-195.8
-159.1
16,417.2
15,816.0
Income Before Tax % Chg.
-
44.5%
276.5%
18.7%
-
37.6%
Income Before Tax Margin
-139.5%
-37.4%
-165.2%
-30.2%
79.3%
78.1%
Income Before Tax Margin % Chg.
-
73.2%
342.3%
81.7%
-
2.2%
Income Tax Expense
0.0
0.7
-0.3
-175.7
5,187.0
4,553.7
Income Tax Expense % Chg.
-
1233.3%
-
59974.6%
-
37.1%
Net Income
-93.5
-52.4
-195.4
16.6
11,230.2
11,262.3
Net Income % Chg.
-
43.9%
272.9%
-
67622.7%
37.8%
Net Income Margin
-139.1%
-37.6%
-164.9%
3.2%
54.2%
55.6%
Net Income Margin % Chg.
-
72.9%
338.1%
-
1621.3%
2.3%
Weighted Avg. Shares Out
226.3
226.3
211.5
253.3
253.3
203.1
Weighted Avg. Shares Out % Chg.
-
-
-6.5%
19.8%
-
-16.5%
EPS
-0.4
-0.2
-0.9
0.1
44.3
74.9
EPS % Chg.
-
44.0%
300.9%
-
67616.7%
122.8%
Weighted Avg. Shares Out Dil
226.3
226.3
211.5
253.3
253.3
214.7
Weighted Avg. Shares Out Dil % Chg.
-
-
-6.5%
19.8%
-
-15.4%
EPS Diluted
-0.4
-0.2
-0.9
0.1
44.3
73.0
EPS Diluted % Chg.
-
44.0%
300.9%
-
67616.7%
124.3%
Interest Income
2.3
2.2
1.9
1.7
1.6
10.9
Interest Income % Chg.
-
-6.4%
-10.8%
-12.2%
-4.1%
489.3%
Interest Expense
0.7
1.9
1.9
2.2
5.9
19.1
Interest Expense % Chg.
-
154.6%
-0.2%
16.6%
169.6%
580.7%
EBIT
-92.1
-51.7
-195.7
-159.6
16,413.0
15,807.9
EBIT % Chg.
-
43.9%
278.5%
18.5%
-
37.5%
EBIT Margin
-137.1%
-37.1%
-165.2%
-30.3%
79.3%
78.0%
EBIT Margin % Chg.
-
72.9%
344.7%
81.6%
-
2.1%
Depreciation & Amortization
11.5
24.0
37.0
42.3
82.1
131.3
Depreciation & Amortization % Chg.
-
108.8%
54.2%
14.3%
94.1%
94.8%
EBITDA
-80.7
-27.7
-158.7
-117.3
16,495.0
15,939.1
EBITDA % Chg.
-
65.6%
472.7%
26.1%
-
37.8%
EBITDA Margin
-120.0%
-19.9%
-134.0%
-22.3%
79.7%
78.7%
EBITDA Margin % Chg.
-
83.4%
572.8%
83.4%
-
2.4%